PATENT CLAIM ANALYSIS

Application Number: 15754934
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "236200"]

Abstract:
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of inflammatory disease and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Claim (Index 4):
The compound or salt according to  claim 1 , wherein Ring B is an optionally further substituted morpholine ring.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.40909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15506380', '15745290', '15210965', '13522070', '14435899']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7837290590299867
- 35 USC 102 Novelty (BERT): 0.5548224997881752
- Combined Prediction Score: 0.7608384031058056
- Mean Citation Score: 361.458788
- Max Citation Score: 406.5847
- Similarity Product: 329.8137386463821

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test